4.8 Article

MicroRNA-7 Deficiency Ameliorates the Pathologies of Acute Lung injury through Elevating KLF4

Journal

FRONTIERS IN IMMUNOLOGY
Volume 7, Issue -, Pages -

Publisher

FRONTIERS MEDIA SA
DOI: 10.3389/fimmu.2016.00389

Keywords

miR-7KD; acute lung injury; immune cells; cytokines; KLF4

Categories

Funding

  1. Program for New Century Excellent Talents in University, Ministry of Education of China [NCET-12-0661]
  2. National Natural Science foundation of China [31370918]
  3. Program for High level innovative talents in Guizhou Province [QKH-RC-2016-4031]
  4. Program for Excellent Young Talents of Zunyi Medical University [15ZY-001]
  5. Project of Guizhou Provincial Department of Science and Technology [2009C491]

Ask authors/readers for more resources

Recent evidence showed that microRNA-7 (miR-7) played an important role in the pathologies of lung-related diseases. However, the potential role of miR-7 in acute lung injury (ALI) still remains poorly understood. Here, we assessed the effect of miR-7 deficiency on the pathology of ALI. We, first, found that the expression of miR-7 was upregulated in lung tissue in murine LPS-induced ALI model. Notably, we generated miR-7 knock down mice by using miRNA-Sponge technique and found that miR-7 deficiency could ameliorate the pathologies of lung as evidenced by accelerated body weight recovery, reduced level of bronchoalveolar lavage (BAL) proinflammatory cytokines and decreased number of BAL cells in ALI mice. Moreover, the proportion and number of various immune cells in BAL, including innate immune cell F4/80(+) macrophages, gamma delta T cells, NK1.1(+) T cells, and CD11c(+) DCs, as well as adaptive immune cell CD4(+) T cells and CD8(+) T cells, also significantly changed, respectively. Mechanistic evidence showed that KLF4, a target molecule of miR-7, was upregulated in lung tissues in ALI model, accompanied by altered transduction of NF-kappa B, AKT, and ERK pathway. These data provided a previously unknown role of miR-7 in pathology of ALI, which could ultimately aid the understanding of development of ALI and the development of new therapeutic strategies against clinical inflammatory lung diseases.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.8
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available